Global Retirement Partners’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.7K Buy
+226
New +$13.6K ﹤0.01% 3071
2025
Q4
$21.8K Sell
626
-45
-7% -$3.54K ﹤0.01% 2831
2025
Q3
$55.8K Sell
671
-135
-17% -$9.77K ﹤0.01% 1834
2025
Q2
$59.2K Buy
+806
New +$58.4K ﹤0.01% 1682
2024
Q4
$7.05K Sell
140
-15
-10% -$786 ﹤0.01% 2526
2024
Q3
$7.17K Sell
155
-3,540
-96% -$126K ﹤0.01% 2408
2024
Q2
$120K Buy
3,695
+3,548
+2,414% +$97.2K ﹤0.01% 1107
2024
Q1
$3.7K Sell
147
-15
-9% -$354 ﹤0.01% 2519
2023
Q4
$3.99K Buy
162
+21
+15% +$577 ﹤0.01% 2415
2023
Q3
$3.65K Hold
141
﹤0.01% 2304
2023
Q2
$3.14K Hold
141
﹤0.01% 2379
2023
Q1
$3.26K Buy
141
+92
+188% +$2.02K ﹤0.01% 2323
2022
Q4
$995 Sell
49
-37
-43% -$927 ﹤0.01% 2598
2022
Q3
$2K Buy
86
+37
+76% +$990 ﹤0.01% 2209
2022
Q2
$1K Sell
49
-12
-20% -$261 ﹤0.01% 2383
2022
Q1
$1K Buy
+61
New +$1.3K ﹤0.01% 2344
2019
Q2
Sell
-790
Closed -$9K 1608
2019
Q1
$9K Hold
790
﹤0.01% 1074
2018
Q4
$11K Hold
790
﹤0.01% 932
2018
Q3
$11K Sell
790
-685
-46% -$9.57K ﹤0.01% 1000
2018
Q2
$23K Buy
+1,475
New +$25.7K 0.01% 751

Other funds holding CORT

Global Retirement Partners's CORT Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 226 shares worth $19.7K. The stake represents ﹤0.01% of the portfolio and ranks #3071 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CORT as recently as Q4 2025.

Global Retirement Partners first reported a position in CORT in Q2 2018 and has held it in 20 quarters since. The position peaked at $120K in Q2 2024. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Global Retirement Partners held 226 shares of Corcept Therapeutics worth $19.7K as of Q2 2026.
  • Corcept Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3071 holding.
  • Global Retirement Partners first reported a position in Corcept Therapeutics in Q2 2018 and has held it in 20 quarters since.
  • Global Retirement Partners's Corcept Therapeutics position peaked at $120K in Q2 2024.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.